4/25
04:08 pm
algs
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study [Yahoo! Finance]
4/25
04:05 pm
algs
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study
Medium
Report
Aligos Therapeutics Presents Positive Clinical Data at ESCMID 2024 from the ALG-097558 Phase 1 Study
4/25
08:10 am
algs
Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD [Yahoo! Finance]
Low
Report
Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD [Yahoo! Finance]
4/25
08:00 am
algs
Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD
Low
Report
Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD
4/9
08:00 am
algs
Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024
Low
Report
Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024
4/3
08:24 am
algs
Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects [Yahoo! Finance]
Medium
Report
Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects [Yahoo! Finance]
4/3
08:00 am
algs
Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
Medium
Report
Aligos Therapeutics Announces First Subjects Dosed in the Phase 2a HERALD Study of ALG-055009 in MASH Subjects
3/27
11:20 am
algs
Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy? [Yahoo! Finance]
Low
Report
Aligos Therapeutics, Inc. (ALGS) Just Flashed Golden Cross Signal: Do You Buy? [Yahoo! Finance]
3/12/2024
04:05 pm
algs
aligos therapeutics, inc. - common stock
BEAT
Report
0.0%
aligos therapeutics, inc. - common stock
11/2/2023
04:05 pm
algs
aligos therapeutics, inc. - common stock
BEAT
Report
1.4%
aligos therapeutics, inc. - common stock
8/3/2023
04:05 pm
algs
aligos therapeutics, inc. - common stock
BEAT
Report
-0.6%
aligos therapeutics, inc. - common stock
5/4/2023
04:05 pm
algs
aligos therapeutics, inc. - common stock
MISS
Report
-8.8%
aligos therapeutics, inc. - common stock
4/16
05:28 pm
algs
Form PRE 14A Aligos Therapeutics, For: Jun 27
Medium
Report
Form PRE 14A Aligos Therapeutics, For: Jun 27
3/12
04:52 pm
algs
Form S-8 Aligos Therapeutics,
Low
Report
Form S-8 Aligos Therapeutics,
3/12
04:16 pm
algs
Form 10-K Aligos Therapeutics, For: Dec 31
Neutral
Report
Form 10-K Aligos Therapeutics, For: Dec 31
3/12
04:06 pm
algs
Form 8-K Aligos Therapeutics, For: Mar 12
Neutral
Report
Form 8-K Aligos Therapeutics, For: Mar 12
3/4
05:45 pm
algs
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: McClure Matthew W.
Medium
Report
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: McClure Matthew W.
3/4
05:43 pm
algs
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: Calhoun Lesley Ann
Medium
Report
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: Calhoun Lesley Ann
3/4
05:42 pm
algs
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: Symons Julian A.
Medium
Report
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: Symons Julian A.
3/4
05:42 pm
algs
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: BLATT LAWRENCE
Medium
Report
Form 4 Aligos Therapeutics, For: Mar 01 Filed by: BLATT LAWRENCE
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register